I would not be surprised if 1) they get bought out or 2) they buy a small bio that has immunotherapy technology that is complimentary to the DCVax platform that is already public, but at a tiny market cap, then reverse merge up to a legit exchange.
Maybe there is even a candidate already? I would not be surprised. I say this after speculating about various signs I see but my speculation so highly speculative that I would not share it. Just a feeling.